Similarly, we showed that melanoma-associated antigen 3 (MAGE-A3) is expressed in undifferentiated pleomorphic sarcoma/myxofibrosarcoma and can be incorporated into immunotherapy techniques [3]. Here, MAGEA3 is linked to undifferentiated pleomorphic sarcoma.